Crosstalk between the nucleotide excision repair and Fanconi anemia/BRCA pathways

DNA Repair

Volumn 19, Issue , 2014, Pages 130-134

  Mouw, Kent W ^a,b   D'Andrea, Alan D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

Author keywords

BRCA; Crosslink repair; Fanconi anemia; Nucleotide excision repair; PARP inhibitor

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BRCA2 PROTEIN; FANCONI ANEMIA PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN, HUMAN;

ARTICLE; CHROMOSOME; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; EPIGENETICS; EXCISION REPAIR; GERMLINE MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; TRANSCRIPTION REGULATION; CELL CYCLE; FANCONI ANEMIA; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

BRCA1 PROTEIN; BRCA2 PROTEIN; CELL CYCLE; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; GERM-LINE MUTATION; HUMANS; SIGNAL TRANSDUCTION;

EID: 84902077532     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.03.019     Document Type: Article

References (42)

1. Kim H., D'Andrea A.D. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev. 2012, 26(13):1393-1408.
2. Rosado I.V., et al. Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway. Nat. Struct. Mol. Biol. 2011, 18(12):1432-1434.
3. Langevin F., et al. Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 2011, 475(7354):53-58.
4. Kee Y., D'Andrea A.D. Molecular pathogenesis and clinical management of Fanconi anemia. J. Clin. Invest. 2012, 122(11):3799-3806.
5. Nijman S.M., et al. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 2005, 17(3):331-339.
6. Scharer O.D. Nucleotide excision repair in eukaryotes. Cold Spring Harbor Perspect. Biol. 2013, 5(10):a012609.
7. Vermeulen W., Fousteri M. Mammalian transcription-coupled excision repair. Cold Spring Harbor Perspect. Biol. 2013, 5(8):a012625.
8. Niedernhofer L.J. Nucleotide excision repair deficient mouse models and neurological disease. DNA Repair (Amst.) 2008, 7(7):1180-1189.
9. Bogliolo M., et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am. J. Hum. Genet. 2013, 92(5):800-806.
10. Kashiyama K., et al. Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia. Am. J. Hum. Genet. 2013, 92(5):807-819.
11. Ahmad A., et al. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients. PLoS Genet. 2010, 6(3):e1000871.
12. Gregg S.Q., Robinson A.R., Niedernhofer L.J. Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease. DNA Repair (Amst.) 2011, 10(7):781-791.
13. Clingen P.H., et al. The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Res. 2005, 33(10):3283-3291.
14. De Silva I.U., et al. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol. Cell Biol. 2000, 20(21):7980-7990.
15. Kaye J., Smith C.A., Hanawalt P.C. DNA repair in human cells containing photoadducts of 8-methoxypsoralen or angelicin. Cancer Res. 1980, 40(3):696-702.
16. Wang X., et al. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol. Cell Biol. 2001, 21(3):713-720.
17. Enoiu M., Jiricny J., Scharer O.D. Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis. Nucleic Acids Res. 2012, 40(18):8953-8964.
18. Shen X., et al. Recruitment of Fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication. Mol. Cell 2009, 35(5):716-723.
19. Kelsall I.R., et al. The Fanconi anaemia components UBE2T and FANCM are functionally linked to nucleotide excision repair. PLoS One 2012, 7(5):e36970.
20. Tubbs J.L., et al. Flipping of alkylated DNA damage bridges base and nucleotide excision repair. Nature 2009, 459(7248):808-813.
21. Marteijn J.A., et al. Nucleotide excision repair-induced H2A ubiquitination is dependent on MDC1 and RNF8 and reveals a universal DNA damage response. J. Cell Biol. 2009, 186(6):835-847.
22. Kamileri I., Karakasilioti I., Garinis G.A. Nucleotide excision repair: new tricks with old bricks. Trends Genet. 2012, 28(11):566-573.
23. Luijsterburg M.S., et al. DDB2 promotes chromatin decondensation at UV-induced DNA damage. J. Cell Biol. 2012, 197(2):267-281.
24. Guerrero-Santoro J., et al. The cullin 4B-based UV-damaged DNA-binding protein ligase binds to UV-damaged chromatin and ubiquitinates histone H2A. Cancer Res. 2008, 68(13):5014-5022.
25. Pines A., et al. PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1. J. Cell Biol. 2012, 199(2):235-249.
26. Sato K., et al. Histone chaperone activity of Fanconi anemia proteins, FANCD2 and FANCI is required for DNA crosslink repair. EMBO J. 2012, 31(17):3524-3536.
27. Hejna J., et al. Tip60 is required for DNA interstrand cross-link repair in the Fanconi anemia pathway. J. Biol. Chem. 2008, 283(15):9844-9851.
28. Citterio E., et al. ATP-dependent chromatin remodeling by the Cockayne syndrome B DNA repair-transcription-coupling factor. Mol. Cell Biol. 2000, 20(20):7643-7653.
29. Le May N., et al. NER factors are recruited to active promoters and facilitate chromatin modification for transcription in the absence of exogenous genotoxic attack. Mol. Cell 2010, 38(1):54-66.
30. Fong Y.W., et al. A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells. Cell 2011, 147(1):120-131.
31. Park E., et al. FANCD2 activates transcription of TAp63 and suppresses tumorigenesis. Mol. Cell 2013, 50(6):908-918.
32. Vinciguerra P., et al. Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. J. Clin. Invest. 2010, 120(11):3834-3842.
33. Naim V., Rosselli F. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat. Cell Biol. 2009, 11(6):761-768.
34. Nalepa G., et al. Fanconi anemia signaling network regulates the spindle assembly checkpoint. J. Clin. Invest. 2013, 123(9):3839-3847.
35. Ito S., et al. MMXD, a TFIIH-independent XPD-MMS19 protein complex involved in chromosome segregation. Mol. Cell 2010, 39(4):632-640.
36. Li X., Urwyler O., Suter B. Drosophila Xpd regulates Cdk7 localization, mitotic kinase activity, spindle dynamics, and chromosome segregation. PLoS Genet. 2010, 6(3):e1000876.
37. Chen J., et al. Xpd/Ercc2 regulates CAK activity and mitotic progression. Nature 2003, 424(6945):228-232.
38. The Cancer Genome Atlas Research Network Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014, 507:315-322.
39. Nijman S.M., Friend S.H. Cancer. Potential of the synthetic lethality principle. Science 2013, 342(6160):809-811.
40. Farmer H., et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005, 434(7035):917-921.
41. Bryant H.E., et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005, 434(7035):913-917.
42. Hilton J.F., et al. Poly(ADP-ribose) polymerase inhibitors as cancer therapy. Front. Biosci. (Landmark Ed.) 2013, 18:1392-1406.